TSX-V:ADK - TSX Venture Exchange - CA2524423068 - Common Stock - Currency: CAD
TSX-V:ADK (3/7/2025, 7:00:00 PM)
0.315
+0 (+0.8%)
The current stock price of ADK.CA is 0.315 CAD. In the past month the price decreased by -3.08%. In the past year, price increased by 12.5%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
KSI.CA | KNEAT.COM INC | N/A | 607.92M | ||
VHI.CA | VITALHUB CORP | 130 | 507.60M | ||
KOVO.CA | KOVO+ HOLDINGS INC | N/A | 7.08M | ||
AVCR.CA | AVRICORE HEALTH INC | N/A | 4.05M | ||
EKG.CA | CARDIOCOMM SOLUTIONS INC | N/A | 2.90M |
Diagnos, Inc. engages in the provision of healthcare technical services through the use of artificial intelligence (AI). The company is headquartered in Brossard, Quebec. The company went IPO on 2000-09-27. FLAIRE allows for quick modifying and developing of applications, such as computer assisted retina analysis (CARA). CARA’s image enhancement algorithms provide sharper, clearer and easier-to-analyze retinal images. CARA is a tool for real-time screening of large volumes of patients. The company provides software-based services to assist health specialists in the detection of diabetic retinopathy and other eye-related pathologies. Its geographical areas include Canada, the United States of America, Mexico, and Chile. The Company’s subsidiaries include Diagnos Internacional SA de CV and Diagnos Healthcare (India) Private Limited.
DIAGNOS INC
7005 Taschereau Blvd Suite 340
Brossard QUEBEC J4Z 1A7 CA
CEO: Andre Larente
Employees: 16
Company Website: https://www.diagnos.com/
Investor Relations: http://www.diagnos.ca/cards/Financial_Reports-en-9
Phone: 14506788882
The current stock price of ADK.CA is 0.315 CAD. The price increased by 0.8% in the last trading session.
The exchange symbol of DIAGNOS INC is ADK and it is listed on the TSX Venture Exchange exchange.
ADK.CA stock is listed on the TSX Venture Exchange exchange.
9 analysts have analysed ADK.CA and the average price target is 1.53 CAD. This implies a price increase of 385.71% is expected in the next year compared to the current price of 0.315. Check the DIAGNOS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
DIAGNOS INC (ADK.CA) has a market capitalization of 31.84M CAD. This makes ADK.CA a Nano Cap stock.
DIAGNOS INC (ADK.CA) currently has 16 employees.
DIAGNOS INC (ADK.CA) has a support level at 0.3 and a resistance level at 0.34. Check the full technical report for a detailed analysis of ADK.CA support and resistance levels.
The Revenue of DIAGNOS INC (ADK.CA) is expected to grow by 4.67% in the next year. Check the estimates tab for more information on the ADK.CA EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
ADK.CA does not pay a dividend.
DIAGNOS INC (ADK.CA) will report earnings on 2025-07-15.
DIAGNOS INC (ADK.CA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.04).
ChartMill assigns a technical rating of 2 / 10 to ADK.CA. When comparing the yearly performance of all stocks, ADK.CA turns out to be only a medium performer in the overall market: it outperformed 42.61% of all stocks.
Over the last trailing twelve months ADK.CA reported a non-GAAP Earnings per Share(EPS) of -0.04. The EPS decreased by -2.5% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -117.56% | ||
ROE | N/A | ||
Debt/Equity | N/A |
ChartMill assigns a Buy % Consensus number of 84% to ADK.CA. The Buy consensus is the average rating of analysts ratings from 9 analysts.
For the next year, analysts expect an EPS growth of -0.49% and a revenue growth 4.67% for ADK.CA